HIV Clinical Trial
Official title:
Repeat STI Patients: Tailored Socio-Contextual Intervention to Reduce HIV Risk
People who present repeatedly at Sexually Transmitted Infection (STI) clinics represent a key
population for HIV prevention intervention research. Despite their heightened risk there is
an absence of empirical research on strategies to intervene with repeat STI. Some STI-clinic
based behavioral HIV prevention studies, focusing on the general STI patient population, have
found that risk reduction interventions can reduce the incidence of a subsequent STI. Studies
have shown that expedited treatment for STI patients' partners can reduce subsequent STI and
enhancing partner notification can reduce risk for repeat infection. Those who go on to
experience repeat infections, after they are provided with risk reduction services, are the
focus of this project. Repeat STI literature noted, there have been no intervention studies
conducted to lower STI/HIV risk specifically among people who are presenting with repeat STI.
The proposed study develops a risk reduction intervention designed for STI repeaters and
evaluates the efficacy of this intervention and its cost-effectiveness. The investigators
expect that the intervention for STI repeaters will be significantly more effective than
standard care with regard to reducing participants' STI/HIV risks. However, even a
highly-effective intervention is unlikely to be adopted if the outcomes come at a high cost.
Administrators need to know how effective a "new" intervention is, but also if it is more
cost-effective than the program it replaces.
Cost-effectiveness information also is critical to justify the "new" intervention to
prevention funders (Milwaukee Department of Health), who are concerned not only with costs
and effects, but also with the tradeoff between them. The proposed study will provide the
comprehensive level of information about intervention effects and cost-effectiveness required
by administrators and resource allocation decision makers to determine whether or not to fund
or implement the intervention.
Hypothesis 1. The investigators expect a greater reduction in unprotected vaginal and anal
intercourse in the prevention case management compared to the standard care condition.
Hypothesis 2. The hypothesis that the case management group will have a lower STI
re-infection rate compared to the standard care group will be tested using each participant's
repeat STI status over the 12 month FU period.
This study is a five-year project to develop and test an intervention to reduce risk among
people at high vulnerability for HIV infection: patients who present repeatedly at sexually
transmitted infection clinics. Repeat bacterial sexually transmitted infections (STI) such as
chlamydia, gonorrhea, trichomoniasis, and syphilis, and repeat visits to STI clinics for
exposure and potential infection, indicate persistent high-risk sexual behavior. Recidivist
patients further represent a significant proportion of public STI clinic visits. Repeat STI
can increase the likelihood of HIV transmission during exposure and some recidivist patients
may serve as "core transmitters," propagating an ongoing epidemic or endemic chain within a
community. Repeat STI patients also face serious health risks from STI complications. In sum,
STI repeaters present significant public health risks and place a large financial and
resource burden on treatment systems.
Patients with repeat STI, by definition, are not adequately served by the prevention services
currently provided by STI clinics. Thus, additional clinic-based services to reduce patients'
risk of future infections of STI and HIV are warranted. Adequately addressing the needs of
repeat STI patients will allow limited resources to be more heavily invested in services for
first-time STI patients who are more likely than recidivist patients to be amenable to
standard clinic-based risk-reduction interventions.
The HIV prevention field has largely been silent about assisting patients who present
repeatedly with STI and STI risk; there are no published studies testing interventions
specifically for repeat STI patients. In addition, most risk-reduction intervention research
based in STI clinics has focused directly on the presenting problem of sexual risk behavior
or addressed a single co-existing factor (substance use, depression). However, research
suggests that repeat STI is related to a wide-ranging and complex configuration of contextual
factors that varies by patient. Indeed, repeat STI is highest among communities with the
highest rates of STI in general, which are characterized by myriad contextual challenges
(unemployment, poverty).
Novel intervention approaches are needed to help repeat STI patients reduce their risk for
HIV infection and for infecting others. Investigators propose to address these gaps in the
HIV and STI prevention literature by focusing on a high-risk group of recidivist patients:
economically disadvantaged urban African Americans. The intervention will help patients
address broader, "risk-regulating" social and contextual factors identified by each patient
(employment, housing, domestic violence, substance abuse). Investigators also will address
individual risk behavior and affective and self-regulatory factors (fatalism, problem solving
skills), that contribute to continued risk behavior and interfere with maintenance of risk
reduction after an STI.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06162897 -
Case Management Dyad
|
N/A | |
Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
Completed |
NCT02528773 -
Efficacy of ART to Interrupt HIV Transmission Networks
|
||
Active, not recruiting |
NCT05454839 -
Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
|
||
Recruiting |
NCT05322629 -
Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women
|
N/A | |
Completed |
NCT02579135 -
Reducing HIV Risk Among Adolescents: Evaluating Project HEART
|
N/A | |
Active, not recruiting |
NCT01790373 -
Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence
|
N/A | |
Not yet recruiting |
NCT06044792 -
The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
|
||
Completed |
NCT04039217 -
Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM
|
Phase 4 | |
Active, not recruiting |
NCT04519970 -
Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK)
|
N/A | |
Completed |
NCT04124536 -
Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women
|
N/A | |
Recruiting |
NCT05599581 -
Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health
|
N/A | |
Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
Completed |
NCT02758093 -
Speed of Processing Training in Adults With HIV
|
N/A | |
Completed |
NCT02500446 -
Dolutegravir Impact on Residual Replication
|
Phase 4 | |
Completed |
NCT03805451 -
Life Steps for PrEP for Youth
|
N/A | |
Active, not recruiting |
NCT03902431 -
Translating the ABCS Into HIV Care
|
N/A | |
Completed |
NCT00729391 -
Women-Focused HIV Prevention in the Western Cape
|
Phase 2/Phase 3 | |
Recruiting |
NCT05736588 -
Elimisha HPV (Human Papillomavirus)
|
N/A | |
Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 |